Physiology and pathophysiology of sphingolipid metabolism and signaling

[81] Purification and characterization of a membrane-bound nonlysosomal ceramidase from rat brain [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (39) : 27948 - 27955

[82] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J]. CELL, 1993, 75 (04) : 817 - 825

[83] Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells from acid sphingomyelinase-deficient mice: Implications for Niemann-Pick disease gene therapy and the development of improved stem cell gene transfer procedures [J]. BLOOD, 1999, 93 (01) : 80 - 86

[84] A neutral magnesium-dependent sphingomyelinase isoform associated with intracellular membranes and reversibly inhibited by reactive oxygen species [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) : 1128 - 1136

[85] Functional characterization of the N-glycosylation sites of human acid sphingomyelinase by site-directed mutagenesis [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2): : 511 - 517

[86] Stimulation of lysosomal sphingomyelin degradation by sphingolipid activator proteins [J]. CHEMISTRY AND PHYSICS OF LIPIDS, 1999, 102 (1-2) : 35 - 43

[87] Landing on lipid rafts [J]. TRENDS IN CELL BIOLOGY, 1999, 9 (06) : 212 - 213

[88] Inhibition of the expression of ornithine decarboxylase and c-Myc by cell-permeant ceramide in difluoromethylornithine-resistant leukaemia cells [J]. BIOCHEMICAL JOURNAL, 1997, 324 : 783 - 789

[89] FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650

[90] CPP32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells [J]. FEBS LETTERS, 1996, 390 (02) : 233 - 237

[81] Purification and characterization of a membrane-bound nonlysosomal ceramidase from rat brain [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (39) : 27948 - 27955

[82] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J]. CELL, 1993, 75 (04) : 817 - 825

[83] Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells from acid sphingomyelinase-deficient mice: Implications for Niemann-Pick disease gene therapy and the development of improved stem cell gene transfer procedures [J]. BLOOD, 1999, 93 (01) : 80 - 86

[84] A neutral magnesium-dependent sphingomyelinase isoform associated with intracellular membranes and reversibly inhibited by reactive oxygen species [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) : 1128 - 1136

[85] Functional characterization of the N-glycosylation sites of human acid sphingomyelinase by site-directed mutagenesis [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2): : 511 - 517

[86] Stimulation of lysosomal sphingomyelin degradation by sphingolipid activator proteins [J]. CHEMISTRY AND PHYSICS OF LIPIDS, 1999, 102 (1-2) : 35 - 43

[87] Landing on lipid rafts [J]. TRENDS IN CELL BIOLOGY, 1999, 9 (06) : 212 - 213

[88] Inhibition of the expression of ornithine decarboxylase and c-Myc by cell-permeant ceramide in difluoromethylornithine-resistant leukaemia cells [J]. BIOCHEMICAL JOURNAL, 1997, 324 : 783 - 789

[89] FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650

[90] CPP32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells [J]. FEBS LETTERS, 1996, 390 (02) : 233 - 237